Chronic spontaneous urticaria: Evidence of systemic microcirculatory changes.

"CONFLICT OF INTEREST STATEMENT Yora Mostmans: reports a grant from The Brugmann Foundation for scientific research in chronic urticaria. Marcus Maurer: declares no conflict of interest in relation to this work. Outside of it, Marcus Maurer is or recently was a speaker and/or advisor for and/or has received research funding from Allakos, Alvotech, Amgen, Aquestive, Aralez, AstraZeneca, Bayer, Celldex, Celltrion, Evommune, GSK, Ipsen, Kyowa Kirin, Leo Pharma, Lilly, Menarini, Mitsubishi Tanabe Pharma, Moxie, Noucor, Novartis, Orion Biotechnology, Resoncance Medicine, Sanofi/Regeneron, Septerna, Trial Form Support International AB, Third HarmonicBio, ValenzaBio, Yuhan Corporation, and Zurabio. Bertrand Richert: declares no conflict of interest in relation to this work. Vanessa Smith: is a Senior Clinical Investigator of the Research Foundation ‐ Flanders (Belgium) (FWO) [1.8.029.20N]. Vanessa Smith is supported by an unrestricted educational chair on systemic sclerosis of Janssen‐Cilag NV. Vanessa Smith has received grant/research support from the Belgian Fund for Scientific Research in Rheumatic Diseases (FWRO) and Boehringer‐Ingelheim Pharma GmbH&Co; consulting fees were provided by Boehringer‐Ingelheim GmbH&Co and Janssen‐Cilag NV; speaker fees were provided by UCB Biopharma Sprl, Boehringer‐Ingelheim GmbH&Co, Janssen‐Cilag NV and Actelion Pharmaceuticals. Karin Melsens: declares no conflict of interest in relation to this work. Viviane De Maertelaer: declares no conflict of interest in relation to this work. Ines Saidi: declares no conflict of interest in relation to this work. Francis Corazza: declares no conflict of interest in relation to this work. Olivier Michel: declares no conflict of interest in relation to this work."

"We thank Asma Benslimane and Thao Tran Thi Thanh for their technical support. Furthermore we would like to thank Martijn Blykers for his graphical design contributions and critical appraisal of the topic. Also, we thank Gillian Brodie for her help with style and syntax of this manuscript. Lastly, we thank The Brugmann Foundation for their financial support of this research. This study was also registered through ClinicalTrials.gov under the name “Role of Endothelial Cells in the Pathogenesis of Chronic Urticaria” ID number: NCT03443362."

"We thank Asma Benslimane and Thao Tran Thi Thanh for their technical support. Furthermore we would like to thank Martijn Blykers for his graphical design contributions and critical appraisal of the topic. Also, we thank Gillian Brodie for her help with style and syntax of this manuscript. Lastly, we thank The Brugmann Foundation for their financial support of this research. This study was also registered through ClinicalTrials.gov under the name “Role of Endothelial Cells in the Pathogenesis of Chronic Urticaria” ID number: NCT03443362."